Market Research Reports

Price range (USD)
$450 up to $22,000

Strategic Intelligence & Industry Research

Explore our library of analyst-validated market research reports. Our intelligence covers critical industry trends, competitive landscapes, and data-driven market forecasts to support your strategic decision-making.

Can’t find the report you need? If our syndicated library doesn’t have the precise data point or scope you are looking for, we provide custom research services designed to deliver the exact intelligence your organization requires.

Displaying 1 - 12 of 305 reports match your search
Navadhi Market Research · Pharmaceuticals
On demand

Global Clotting Factor VIII Market Strategic Research Report

The global Clotting Factor VIII market occupies a critical position within the broader hemophilia therapeutics landscape, addressing the needs of patients with Hemop…

$9.7B
2025
$14B
2032
▲ 5.4%CAGR2025–2032
5.4% CAGR $9.7B dans 2025 150 pages Global
3 500,00 $US from
Forecast $14B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Clotting Factor Market Strategic Research Report

The global clotting factor market represents one of the most clinically critical and commercially significant segments within hematology therapeutics. Driven by pers…

$14.3B
2025
$22.7B
2032
▲ 6.8%CAGR2025–2032
6.8% CAGR $14.3B dans 2025 150 pages Global
3 500,00 $US from
Forecast $22.7B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Dihydroorotate Dehydrogenase (DHODH) Inhibitor Market Strategic Research Report

The global dihydroorotate dehydrogenase (DHODH) inhibitor market represents one of the more strategically significant niches within small-molecule immunology and onc…

$1.87B
2025
$3.3B
2032
▲ 8.3%CAGR2025–2032
8.3% CAGR $1.87B dans 2025 150 pages Global
3 500,00 $US from
Forecast $3.3B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Synthetic Lethality Oncology Drug Pipeline Market Strategic Research Report

The global synthetic lethality oncology drug pipeline market represents one of the most scientifically compelling frontiers in precision oncology, valued at approxim…

$6.8B
2025
$16.4B
2032
▲ 13.4%CAGR2025–2032
13.4% CAGR $6.8B dans 2025 Global
3 500,00 $US from
Forecast $16.4B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global JAK Inhibitors and Targeted Biologics for Autoimmune Diseases Market Strategic Research Report

The global JAK inhibitors and targeted biologics for autoimmune diseases market represents one of the most commercially significant segments within immunology therap…

$42.8B
2025
$81.8B
2032
▲ 9.7%CAGR2025–2032
9.7% CAGR $42.8B dans 2025 Global
3 500,00 $US from
Forecast $81.8B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Immune Checkpoint Inhibitors and Combination Therapies Market Strategic Research Report

The global immune checkpoint inhibitors (ICI) and combination therapies market represented one of the most consequential shifts in oncology over the past decade, rea…

$58.4B
2025
$144.3B
2032
▲ 13.8%CAGR2025–2032
13.8% CAGR $58.4B dans 2025 Global
3 500,00 $US from
Forecast $144.3B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global KRAS G12C and Pan-KRAS Inhibitors Market Strategic Research Report

The global KRAS G12C and Pan-KRAS inhibitors market represents one of the most consequential frontiers in targeted oncology therapeutics, addressing mutations in the…

$2.8B
2025
$11.8B
2032
▲ 22.8%CAGR2025–2032
22.8% CAGR $2.8B dans 2025 Global
3 500,00 $US from
Forecast $11.8B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Matrix-Metalloproteinase Inhibitor Targeted Therapeutics Market Strategic Research Report

The global matrix-metalloproteinase (MMP) inhibitor targeted therapeutics market represents one of oncology and inflammatory disease research's most consequential fr…

$2.8B
2025
$5.2B
2032
▲ 9.1%CAGR2025–2032
9.1% CAGR $2.8B dans 2025 Global
3 500,00 $US from
Forecast $5.2B by 2032
View report
Navadhi Market Research · Biotechnology & Life Sciences
On demand

Global Fibroblast Growth Factor Receptor 3 (FGFR3) ELISA Kit Market Strategic Research Report

The global Fibroblast Growth Factor Receptor 3 (FGFR3) ELISA Kit market is a specialized segment within the broader in vitro diagnostics and life science research to…

$47.3
2025
$82.7
2032
▲ 8.3%CAGR2025–2032
8.3% CAGR $47.3 dans 2025 150 pages Global
3 500,00 $US from
Forecast $82.7 by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Small Molecule Ubiquitin-Proteasome System (UPS) and PROTACs Market Strategic Research Report

The global small molecule ubiquitin-proteasome system (UPS) and proteolysis-targeting chimeras (PROTACs) market represents one of the most consequential frontiers in…

$4.1B
2025
$13.3B
2032
▲ 18.3%CAGR2025–2032
18.3% CAGR $4.1B dans 2025 Global
3 500,00 $US from
Forecast $13.3B by 2032
View report
Navadhi Market Research · Biotechnology & Life Sciences
On demand

Global Recombinant Therapeutics Market Strategic Research Report

The global recombinant therapeutics market represents one of the most commercially consequential segments of modern biopharmaceutical manufacturing, encompassing pro…

$392B
2025
$667.5B
2032
▲ 7.9%CAGR2025–2032
7.9% CAGR $392B dans 2025 Global
3 500,00 $US from
Forecast $667.5B by 2032
View report
Navadhi Market Research · Biotechnology & Life Sciences
On demand

Global Anti-Neoplastic Agents Market Strategic Research Report

The global anti-neoplastic agents market represents one of the most capital-intensive and scientifically sophisticated segments of the pharmaceutical industry, encom…

$196.8B
2025
$355.2B
2032
▲ 8.8%CAGR2025–2032
8.8% CAGR $196.8B dans 2025 Global
3 500,00 $US from
Forecast $355.2B by 2032
View report